Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 863

1.

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.

Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, Coric V, Lipton RB.

Lancet. 2019 Jul 12. pii: S0140-6736(19)31606-X. doi: 10.1016/S0140-6736(19)31606-X. [Epub ahead of print]

PMID:
31311674
2.

Migraine Progression: A Systematic Review. An Editorial Comment.

Buse DC, Greisman JD, Baigi K, Lipton RB.

Headache. 2019 Jul;59(7):974-976. doi: 10.1111/head.13573. No abstract available.

PMID:
31297806
3.

Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.

Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, Dubowchik GM, Conway CM, Coric V, Goadsby PJ.

N Engl J Med. 2019 Jul 11;381(2):142-149. doi: 10.1056/NEJMoa1811090.

PMID:
31291516
4.

Assessing diagnostic error in cerebral venous thrombosis via detailed chart review.

Liberman AL, Bakradze E, Mchugh DC, Esenwa CC, Lipton RB.

Diagnosis (Berl). 2019 Jul 4. pii: /j/dx.ahead-of-print/dx-2019-0003/dx-2019-0003.xml. doi: 10.1515/dx-2019-0003. [Epub ahead of print]

PMID:
31271550
5.

Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.

Ford JH, Ayer DW, Zhang Q, Carter JN, Leroux E, Skljarevski V, Aurora SK, Tockhorn-Heidenreich A, Lipton RB.

Neurology. 2019 Jul 3. pii: 10.1212/WNL.0000000000007856. doi: 10.1212/WNL.0000000000007856. [Epub ahead of print]

PMID:
31270220
6.

Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine.

Farris SG, Thomas JG, Abrantes AM, Lipton RB, Burr EK, Godley FA, Roth JL, Pavlovic JM, Bond DS.

Cephalalgia. 2019 Jul 1:333102419861712. doi: 10.1177/0333102419861712. [Epub ahead of print]

PMID:
31260336
7.

A Birth Cohort Analysis of Amnestic Mild Cognitive Impairment Incidence in the Einstein Aging Study (EAS) Cohort.

Derby CA, Katz MJ, Rozner S, Lipton RB, Hall CB.

J Alzheimers Dis. 2019 Jun 24. doi: 10.3233/JAD-181141. [Epub ahead of print]

PMID:
31256119
8.

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.

Dodick DW, Lipton RB, Silberstein S, Goadsby PJ, Biondi D, Hirman J, Cady R, Smith J.

Cephalalgia. 2019 Aug;39(9):1075-1085. doi: 10.1177/0333102419858355. Epub 2019 Jun 24.

PMID:
31234642
9.

A coordinated multi-study analysis of the longitudinal association between handgrip strength and cognitive function in older adults.

Zammit AR, Piccinin AM, Duggan EC, Koval A, Clouston S, Robitaille A, Brown CL, Handschuh P, Wu C, Jarry V, Finkel D, Graham RB, Muniz-Terrera G, Björk MP, Bennett D, Deeg DJ, Johansson B, Katz MJ, Kaye J, Lipton RB, Martin M, Pederson NL, Spiro A, Zimprich D, Hofer SM.

J Gerontol B Psychol Sci Soc Sci. 2019 Jun 11. pii: gbz072. doi: 10.1093/geronb/gbz072. [Epub ahead of print]

PMID:
31187137
10.

Pathophysiology, prevention, and treatment of medication overuse headache.

Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, Porreca F, Silberstein S, Schwedt T.

Lancet Neurol. 2019 Jun 4. pii: S1474-4422(19)30146-2. doi: 10.1016/S1474-4422(19)30146-2. [Epub ahead of print] Review.

PMID:
31174999
11.

Anxiety Sensitivity as a Risk Indicator for Anxiety, Depression, and Headache Severity in Women With Migraine.

Farris SG, Burr EK, Abrantes AM, Thomas JG, Godley FA, Roth JL, Lipton RB, Pavlovic JM, Bond DS.

Headache. 2019 Jun 5. doi: 10.1111/head.13568. [Epub ahead of print]

PMID:
31166015
12.

Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study.

Verghese J, Wang C, Bennett DA, Lipton RB, Katz MJ, Ayers E.

Alzheimers Dement. 2019 Jun 1. pii: S1552-5260(19)30085-8. doi: 10.1016/j.jalz.2019.03.011. [Epub ahead of print]

PMID:
31164315
13.

Health-related Quality of Life, Cognitive Performance, and Incident Dementia in a Community-based Elderly Cohort.

Ezzati A, Zammit AR, Katz MJ, Derby CA, Zimmerman ME, Lipton RB.

Alzheimer Dis Assoc Disord. 2019 May 22. doi: 10.1097/WAD.0000000000000324. [Epub ahead of print]

PMID:
31135451
14.

The relationship between hippocampal volume, chronic pain, and depressive symptoms in older adults.

Ezzati A, Zammit AR, Lipton ML, Lipton RB.

Psychiatry Res Neuroimaging. 2019 Jul 30;289:10-12. doi: 10.1016/j.pscychresns.2019.05.003. Epub 2019 May 15.

PMID:
31112826
15.

Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.

Dodick DW, Silberstein SD, Lipton RB, DeGryse RE, Adams AM, Diener HC.

Cephalalgia. 2019 Jul;39(8):945-956. doi: 10.1177/0333102418825382. Epub 2019 May 21.

PMID:
31112399
16.

Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.

Ezzati A, Zammit AR, Habeck C, Hall CB, Lipton RB; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2019 May 18. doi: 10.1007/s11682-019-00115-6. [Epub ahead of print]

PMID:
31104279
17.

Timing of onset and rate of decline in learning and retention in the pre-dementia phase of Alzheimer's disease.

Grober E, An Y, Lipton RB, Kawas C, Resnick SM.

J Int Neuropsychol Soc. 2019 May 16:1-7. doi: 10.1017/S1355617719000304. [Epub ahead of print]

PMID:
31094304
18.

Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial.

McGinley JS, Buse DC, Shulman KJ, Wirth RJ, Hugentobler E, Lipton RB.

Headache. 2019 Jul;59(7):1002-1013. doi: 10.1111/head.13530. Epub 2019 May 7.

PMID:
31062349
19.

Cardiovascular disease risk factor burden and cognition: Implications of ethnic diversity within the Hispanic Community Health Study/Study of Latinos.

Lamar M, Durazo-Arvizu RA, Sachdeva S, Pirzada A, Perreira KM, Rundek T, Gallo LC, Grober E, DeCarli C, Lipton RB, Tarraf W, González HM, Daviglus ML.

PLoS One. 2019 Apr 22;14(4):e0215378. doi: 10.1371/journal.pone.0215378. eCollection 2019.

20.

Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.

Lipton RB, Tepper SJ, Reuter U, Silberstein S, Stewart WF, Nilsen J, Leonardi DK, Desai P, Cheng S, Mikol DD, Lenz R.

Neurology. 2019 May 7;92(19):e2250-e2260. doi: 10.1212/WNL.0000000000007452. Epub 2019 Apr 17.

21.

Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?

Hershey LA, Lipton RB.

Neurology. 2019 Apr 30;92(18):829-830. doi: 10.1212/WNL.0000000000007233. Epub 2019 Apr 5. No abstract available.

PMID:
30952790
22.

Relationship Between Treatment Initiation and Healthcare Costs in Alzheimer's Disease.

Black CM, Lipton RB, Thiel E, Brouillette M, Khandker R.

J Alzheimers Dis. 2019;68(4):1575-1585. doi: 10.3233/JAD-180983.

PMID:
30909221
24.

Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.

Speck RM, Shalhoub H, Wyrwich KW, Yu R, Ayer DW, Ford J, Bush EN, Lipton RB.

Headache. 2019 May;59(5):756-774. doi: 10.1111/head.13497. Epub 2019 Mar 12.

25.

Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.

Pavlovic JM, Yu JS, Silberstein SD, Reed ML, Kawahara SH, Cowan RP, Dabbous F, Campbell KL, Shewale AR, Pulicharam R, Kowalski JW, Viswanathan HN, Lipton RB.

Cephalalgia. 2019 Apr;39(4):465-476. doi: 10.1177/0333102418825373. Epub 2019 Mar 9.

26.

A Multi-Study Coordinated Meta-Analysis of Pulmonary Function and Cognition in Aging.

Duggan EC, Piccinin AM, Clouston S, Koval AV, Robitaille A, Zammit AR, Wu C, Brown CL, Lee LO, Finkel D, Beasley WH, Kaye J, Muniz-Terrera G, Katz M, Lipton RB, Deeg D, Bennett DA, Björk MP, Johansson B, Spiro A, Weuve J, Hofer SM.

J Gerontol A Biol Sci Med Sci. 2019 Mar 2. pii: glz057. doi: 10.1093/gerona/glz057. [Epub ahead of print]

PMID:
30825374
27.

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomić H, Frosch MP, Thonberg H, Maier W, Roschupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Andre Uitterlinden AG, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Bossù P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y; Alzheimer Disease Genetics Consortium (ADGC),; European Alzheimer’s Disease Initiative (EADI),; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE),; Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES),, Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz J, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, C O'Donovan M, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA.

Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28.

PMID:
30820047
28.

Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J; International Headache Society Clinical Trials Standing Committee.

Cephalalgia. 2019 May;39(6):687-710. doi: 10.1177/0333102419828967. Epub 2019 Feb 26.

29.

Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.

Dodick DW, Reed ML, Fanning KM, Munjal S, Alam A, Buse DC, Schwedt TJ, Lipton RB.

Cephalalgia. 2019 Jun;39(7):873-882. doi: 10.1177/0333102418825346. Epub 2019 Feb 7.

PMID:
30732460
30.

Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.

Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, Blumenfeld AM.

J Headache Pain. 2019 Feb 1;20(1):12. doi: 10.1186/s10194-018-0953-0.

31.

Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments.

Lipton RB, Silberstein S.

Prim Care Companion CNS Disord. 2018 Dec 27;20 suppl E1. pii: li17059su1c. doi: 10.4088/PCC.li17059su1c.

PMID:
30698925
32.

Migraine day frequency in migraine prevention: longitudinal modelling approaches.

Di Tanna GL, Porter JK, Lipton RB, Brennan A, Palmer S, Hatswell AJ, Sapra S, Villa G.

BMC Med Res Methodol. 2019 Jan 23;19(1):20. doi: 10.1186/s12874-019-0664-5.

33.

Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study.

Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, Blumenfeld AM.

J Headache Pain. 2019 Jan 22;20(1):10. doi: 10.1186/s10194-018-0952-1.

34.

Depressive Symptoms Predict Incident Dementia in a Community Sample of Older Adults: Results From the Einstein Aging Study.

Ezzati A, Katz MJ, Derby CA, Zimmerman ME, Lipton RB.

J Geriatr Psychiatry Neurol. 2019 Jan 10:891988718824036. doi: 10.1177/0891988718824036. [Epub ahead of print]

PMID:
30630387
35.

Migraine Progression: A Systematic Review.

Buse DC, Greisman JD, Baigi K, Lipton RB.

Headache. 2019 Mar;59(3):306-338. doi: 10.1111/head.13459. Epub 2018 Dec 27. Review.

PMID:
30589090
36.

The Temporal Relationship between Pain Intensity and Pain Interference and Incident Dementia.

Ezzati A, Wang C, Katz MJ, Derby CA, Zammit AR, Zimmerman ME, Pavlovic JM, Sliwinski MJ, Lipton RB.

Curr Alzheimer Res. 2019;16(2):109-115. doi: 10.2174/1567205016666181212162424.

37.

Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.

Zammit AR, Muniz-Terrera G, Katz MJ, Hall CB, Ezzati A, Bennett DA, Lipton RB.

J Alzheimers Dis. 2019;67(1):125-135. doi: 10.3233/JAD-180737.

38.

Parkinson's disease: Evolution of the scientific literature from 1983 to 2017 by countries and journals.

Robert C, Wilson CS, Lipton RB, Arreto CD.

Parkinsonism Relat Disord. 2019 Apr;61:10-18. doi: 10.1016/j.parkreldis.2018.11.011. Epub 2018 Nov 10. Review.

PMID:
30455157
39.

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.

Kuca B, Silberstein SD, Wietecha L, Berg PH, Dozier G, Lipton RB; COL MIG-301 Study Group.

Neurology. 2018 Dec 11;91(24):e2222-e2232. doi: 10.1212/WNL.0000000000006641. Epub 2018 Nov 16.

40.

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease.

Peloso GM, van der Lee SJ; International Genomics of Alzheimer's Project (IGAP), Destefano AL, Seshardi S.

Alzheimers Dement (Amst). 2018 Sep 22;10:595-598. doi: 10.1016/j.dadm.2018.08.008. eCollection 2018.

41.

Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, Lipton RB.

Headache. 2019 Jan;59(1):32-45. doi: 10.1111/head.13435. Epub 2018 Nov 1.

42.

Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials.

Porter JK, Di Tanna GL, Lipton RB, Sapra S, Villa G.

Pharmacoecon Open. 2018 Oct 30. doi: 10.1007/s41669-018-0105-0. [Epub ahead of print]

43.

Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.

Dodick DW, Tepper SJ, Lipton RB, Buse DC, Stewart WF, Bayliss M, Desai P, Sapra S, Anderson K, McInerney-Prichard E.

Headache. 2018 Oct;58(9):1358-1372. doi: 10.1111/head.13426.

PMID:
30362524
44.

Visual memory tests enhance the identification of amnestic MCI cases at greater risk of Alzheimer's disease.

Oltra-Cucarella J, Sánchez-SanSegundo M, Lipnicki DM, Crawford JD, Lipton RB, Katz MJ, Zammit AR, Scarmeas N, Dardiotis E, Kosmidis MH, Guaita A, Vaccaro R, Kim KW, Han JW, Kochan NA, Brodaty H, Pérez-Vicente JA, Cabello-Rodríguez L, Sachdev PS, Ferrer-Cascales R; Cohort Studies of Memory in an International Consortium (COSMIC).

Int Psychogeriatr. 2018 Oct 25:1-10. doi: 10.1017/S104161021800145X. [Epub ahead of print]

PMID:
30355384
45.

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.

Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.

Headache. 2018 Oct;58(9):1408-1426. doi: 10.1111/head.13407. Epub 2018 Oct 20.

PMID:
30341895
46.

The Association of Changes in Pain Acceptance and Headache-Related Disability.

Lillis J, Thomas JG, Lipton RB, Rathier L, Roth J, Pavlovic J, O'Leary KC, Bond DS.

Ann Behav Med. 2019 Jun 4;53(7):686-690. doi: 10.1093/abm/kay076.

PMID:
30289426
47.

Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.

Zammit AR, Hall CB, Katz MJ, Muniz-Terrera G, Ezzati A, Bennett DA, Lipton RB.

J Alzheimers Dis. 2018;66(1):347-357. doi: 10.3233/JAD-180604.

48.

Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.

Katz MJ, Wang C, Derby CA, Lipton RB, Zimmerman ME, Sliwinski MJ, Rabin LA.

J Alzheimers Dis. 2018;66(1):239-248. doi: 10.3233/JAD-180335.

PMID:
30282356
49.

Negative and positive affect as predictors of inflammation: Timing matters.

Graham-Engeland JE, Sin NL, Smyth JM, Jones DR, Knight EL, Sliwinski MJ, Almeida DM, Katz MJ, Lipton RB, Engeland CG.

Brain Behav Immun. 2018 Nov;74:222-230. doi: 10.1016/j.bbi.2018.09.011. Epub 2018 Sep 11.

PMID:
30217538
50.

American Headache Society Survey About Urgent and Emergency Management of Headache Patients.

Minen MT, Ortega E, Lipton RB, Cowan R.

Headache. 2018 Oct;58(9):1389-1396. doi: 10.1111/head.13387. Epub 2018 Sep 12.

PMID:
30207384

Supplemental Content

Loading ...
Support Center